The ICJ today called on the UN Human Rights Council to establish a strong Commission of Inquiry to counter impunity for crimes under international law and violations of human rights and international humanitarian law following the agression of the Russian Federation against Ukraine.
An opinion piece by ICJ Commissioner, Rodrigo Uprimny, asks whether the existing COVID-19 vaccine patenting arrangements favouring the intellectual property interests of pharmaceuticals come at an unacceptable cost to protecting the life and health of millions. Commissioner Uprimny is also Researcher at Dejusticia and member of the UN Committee on Economic, Social and Cultural Rights.
During an informal conversation I was asked:
“Why is it that, although so many of us are dying due to COVID-19 and suffering from the dramatic state of the economy, we continue to wait for vaccines despite the availability of so many safe and effective ones? Is it that we cannot produce the vaccines locally?
The answer to this simple but essential question is that vaccine access is no longer a technical but also a political issue.
While Colombia cannot technically manufacture or produce some COVID-19 vaccines such as those based on the RNA messengers, many other countries, including several in the global South such as India, Argentina or Brazil, could. As has been highlighted by Doctors without Borders, there is no technical obstacle to mass vaccine production that would allow to vaccinate every one of the 7.8 billion human beings on earth within a few months
Instead, the obstacle is legal and political. It is the intellectual property that provides patents to pharmaceutical companies, who have developed COVID-19 vaccines. That creates a temporary monopoly. During such a temporary monopoly period, which usually lasts 20 years, no other company can produce their vaccines without permissions. As a consequence, those companies can impose and regulate the prices and conditions for the production of their vaccines.
Patents are defended by high-income countries, where many large pharmaceutical companies are based. They argue that there would be no innovation without patents as companies would not have incentives to research and develop new products.
Here, I will not dispute this defense of intellectual property, which is highly debatable. I would instead like to pose this question: even if patents were good and helped innovation, is it fair that they remain intact during the COVID-19 pandemic if they prevent rapid access to vaccines all over the world? The answer to this question is no, because we are condemning millions of people to die, but also because the epidemiological risks are extremely high. Each contagion poses a new risk for a novel coronavirus mutation that may eventually result in a variant that could escape the efficacy of current vaccines. It is also possible that a new mutation has a severe impact on the health of children, who have been somewhat spared from the more lethal impacts of COVID-19 until now.
In light of the current situation, without challenging the institution of intellectual property as such, South Africa and India issued a proposal to the World Trade Organization, the international organization overseeing such trade-related issues. They proposed a temporary exemption (or “waiver”) of patents on vaccines and treatments for COVID-19 at least until the pandemic is under control. A potential, fair compensation for companies who discovered the vaccines might also been considered, although obviously discounting the immense financial support they have already received from public funding.
This temporary exemption is crucial as current flexibilities in patent rights, such as compulsory licenses, are too rigid and limited to face the current crisis. This waiver provides the only opportunity for companies and States, with sufficient technical capabilities, to mass-produce necessary vaccines without having to fear the severe penalties of patent (intellectual property) violations.
While this proposal continues to face resistance from certain countries in the Global North, it is receiving growing support from many states, scientific and humanitarian organizations. Regrettably, the Colombian government has refrained from supporting it, with the shameful argument that more evidence needs to be provided. More evidence of what? Does it not suffice that we currently do not have access to necessary vaccines, although technically we could produce ample amounts? Or that available vaccines are, above all, headed to high-income nations? And is this mainly due to patents on vaccines that, far from being a fair award for innovation, seem to be letters of marque in favor of pharmaceutical companies, without any consideration of deaths and harms caused by the global lack of COVID-19 vaccines?
This op-ed was first published on El Espectador, 27 February 2021.
Download the Op-Ed in English and Spanish.
ICJ Statements on Vaccine Access:
Global: “ICJ calls on States to ensure human rights compliant access to COVID-19 vaccines (UN Statement)”: (1 March 2021)
Global: “ICJ urges the UN Committee on Economic, Social and Cultural Rights to call on States to comply with their obligations to ensure equitable access to vaccines for all” (15 Feb 2021): https://www.icj.org/icj-urges-the-un-committee-on-economic-social-and-cultural-rights-to-call-on-states-to-comply-with-their-obligations-to-ensure-equitable-access-to-vaccines-for-all/
Peru: “The COVID-19 vaccine demands international and national solidarity” (23 Feb 2021): https://www.icj.org/the-covid-19-vaccine-demands-international-and-national-solidarity/
Africa: “The ICJ recommends that the African Union acknowledge COVID-19 vaccines are a “public good” (4 Feb 2021): https://www.icj.org/the-icj-recommends-that-the-african-union-acknowledge-covid-19-vaccines-are-a-public-good/
Zimbabwe: “The ICJ and ZimRights ask for urgent intervention on access to COVID-19 vaccines from African Commission Mechanism” (19 Feb 2021): https://www.icj.org/the-icj-and-zimrights-ask-for-urgent-intervention-on-access-to-covid-19-vaccines-from-african-commission-mechanism/
Further reading:
UN Special Procedures: “COVID-19: UN experts urge WTO cooperation on vaccines to protect global public health” (1 March 2021): https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=26817&LangID=E
UN Special Procedures: “Statement by UN Human Rights Experts Universal access to vaccines is essential for prevention and containment of COVID-19 around the world” (9 Nov 2020): https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=26484&LangID=E
UN CESCR Committee: “Statement on universal and equitable access to vaccines for the coronavirus disease (COVID-19)” (27 Nov 2020) https://tbinternet.ohchr.org/_layouts/15/treatybodyexternal/Download.aspx?symbolno=E/C.12/2020/2&Lang=en
IACHR and its SRESCER: “IACHR and its SRESCER Call on American States to Make Public Health and Human Rights the Focus of All their Decisions and Policies Concerning the COVID-19 Vaccine” (5 Feb 2021): http://www.oas.org/en/IACHR/jsForm/?File=/en/iachr/media_center/PReleases/2021/027.asp
In a new report published today, the ICJ called on all States to ensure that their responses to the public health emergency brought on by the COVID-19 comply with the international human rights law and the right to health.
The report emphasized the particularly acute and discriminatory impact of the pandemic on already marginalized people and the need for access to health facilities, goods and services necessary to combat COVID-19 without discrimination.
The report Living Like People Who Die Slowly: The Need for Right to Health Compliant COVID-19 Responses documents the adverse human rights effects wrought by the COVID-19 pandemic.
The title comes from the words of Mama Yuli, an Indonesian transwoman, who has said that the pandemic left many elderly transwomen feeling like “they live like people who die slowly”.
The report emphasizes the need for a human rights and rule of law-based approach to the pandemic, with States working cooperatively to address a health crisis that by its nature knows no national boundaries.
“The COVID-19 pandemic is public health crisis that presents immeasurable threats to human rights and the rule of law globally, said Ian Seiderman, the ICJ’s Legal and Policy Director.
“But what is crucial is that States responses themselves not only respond immediately and effectively to COVID-19 as a public health emergency, but also as a human rights crisis”, he added.
Building on the ICJ’s earlier responses to COVID-19, the report details the disproportionate impact of COVID-19 on non-citizens, older persons, women and girls, LGBT persons, persons deprived of their liberty, persons with disabilities, sex workers and healthcare workers.
The report also emphasizes the need for the provision of health information by State authorities in the context of COVID-19 and scrutinizes measures taken by States which have often curbed the rights to freedom of expression, information and privacy.
For example, though “contracting tracing” measures may be effective they must also be human rights compliant and information gathered through such measures should not be used inappropriately or as an instrument of repression of individuals and human defenders.
Acknowledging the interconnectedness of all human rights, the report emphasizes the need for States to ensure provision and protection of access to the “social determinants of health” such as housing, food and water, themselves also internationally protected rights.
The report provides recommendations to States that may assist in ensuring right to health and human rights compliant responses to COVID-19.
The ICJ called on States to respect the various guidance offered by UN human rights treaty bodies and independent experts on how best to comply with their human rights obligations while responding to the pandemic.
The human rights system provides important guidance to States that was not available, for example, during the 1918 influenza pandemic, which ultimately resulted in an estimated 50 million deaths.
“States must heed these calls for a human rights and rule of law-based response to COVID-19, as failure to do so will certainly result in death and human suffering that can still be avoided,” said Seiderman.
The report also raises the importance of compliance by businesses, including particularly private actors in the healthcare sector, with their responsibility to respect human rights, including the right to health.
This will be critical, for example, in ensuring the success of combined efforts of States and private companies in the development and ultimate distribution of a COVID-19 vaccine.
Contact
Timothy Fish Hodgson, ICJ Legal Adviser on Economic, Social and Cultural Rights, t: +27828719905 e: timothy.hodgson@icj.org
Download
Universal-Global Health COVID-19 Exec Sum-Publications-Reports-Thematic Reports-2020-ENG (Executive Summary, in PDF)
Universal-Global Health COVID-19-Publications-Reports-Thematic Reports-2020-ENG (Full report, in PDF)
Myanmar-ICJ-Right-to-Health-Report-2021-BUR.pdf (Full report in Burmese)
Read also
COVID-19 Symposium: COVID-19 Responses and State Obligations Concerning the Right to Health (Part 1)
COVID-19 Symposium: COVID-19 Responses and State Obligations Concerning the Right to Health (Part 2)
Watch